Related Experiment Video
Updated: Dec 10, 2025

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
Single Cell Glucose Uptake Assays: A Cautionary Tale
Linda V Sinclair1, Celine Barthelemy2, Doreen A Cantrell1
1Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, DD1 4HN, UK.
Insights
The fluorescent glucose analog 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG) is not a reliable measure of glucose transport in T cells. Its uptake does not correlate with actual glucose transport capacity in these immune cells.
Area of Science:
- Immunology
- Cellular Metabolism
- Biochemistry
Background:
- Assays for single-cell immune cell metabolic state and nutrient uptake are crucial.
- 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG) is a fluorescent glucose analog used to study glucose uptake.
- 2-NBDG is validated for Glut2 but its selectivity for T cell glucose transporters (Glut1, Glut3) and non-transporter binding is unexplored.
Purpose of the Study:
- To investigate the specificity of 2-NBDG labeling as a readout for glucose transport in T lymphocytes.
- To assess whether 2-NBDG uptake accurately reflects glucose transport capacity in T cells.
- To determine if 2-NBDG binds to T cells independently of glucose transporters.
Main Methods:
- Comparison of flow cytometric 2-NBDG staining with radiolabeled glucose transport assays in murine T cells.
- Assessment of 2-NBDG uptake inhibition by competitive substrates and glucose transporter inhibitors.
- Evaluation of 2-NBDG's ability to competitively inhibit glucose uptake.
Main Results:
- Significant discordance observed between glucose transport capacity and 2-NBDG labeling in T cells.
- 2-NBDG uptake in murine T cells was not inhibited by known glucose transport inhibitors or competitive substrates.
- 2-NBDG did not competitively block glucose uptake in T cells.
Conclusions:
- 2-NBDG uptake alone is not a reliable tool for assessing cellular glucose transport capacity in T lymphocytes.
- The mechanism of 2-NBDG uptake in T cells may not involve canonical glucose transporters.
- Further research is needed to validate alternative methods for measuring T cell glucose uptake.
Abstract:
Assays to monitor the metabolic state or nutrient uptake capacity of immune cells at a single cell level are increasingly in demand. One assay, used by many immunologists, employs 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG), a fluorescent analogue of 2-deoxyglucose (2DG), as a substrate for glucose transporters. This molecule has been validated as a substrate for the glucose transporter Glut2 (Slc2a2) in mammalian cells but 2-NDBG selectivity for the glucose transporters expressed by T cells, Glut1 (Slc2a1) and Glut3 (Slc2a3), has never been explored. Nor has the possibility that 2-NBDG might bind to T cells that do not express glucose transporters been assessed. In this technical commentary we interrogate the specificity of 2-NBBG labelling as a readout for glucose transport in T lymphocytes. We compare flow cytometric 2-NBDG staining against well validated radiolabelled glucose transport assays in murine T cells. Our data show there can be a large discordance between glucose transport capacity and 2-NBDG labelling in T cells. We also find that 2-NBDG uptake into murine T cells is not inhibited by competitive substrates or facilitative glucose transporter inhibitors, nor can 2-NBDG competitively block glucose uptake in T cells. Collectively, these data argue that 2-NBDG uptake alone is not a reliable tool for the assessment of cellular glucose transport capacity.
More Related Videos
08:03Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
06:28A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood
Published on: August 12, 2016